|
1
|
Waly Raphael S, Yangde Z and Yuxiang C:
Hepatocellular carcinoma: Focus on different aspects of management.
ISRN Oncol. 2012:4216732012.PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistic, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaufhold S and Bonavida B: Central role of
Snail1 in the regulation of EMT and resistance in cancer: A target
for therapeutic intervention. J Exp Clin Cancer Res. 33:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Christiansen JJ and Rajasekaran AK:
Reassessing epithelial to mesenchymal transition as a prerequisite
for carcinoma invasion and metastasis. Cancer Res. 66:8319–8326.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee TK, Poon RT, Yuen AP, Ling MT, Kwok
WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL and Fan ST: Twist
overexpression correlates with hepatocellular carcinoma metastasis
through induction of epithelialmesenchymal transition. Clin Cancer
Res. 12:5369–5376. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suzuki A, Kusakai G, Kishimoto A, Lu J,
Ogura T, Lavin MF and Esumi H: IdentiWcation of a novel protein
kinase mediating Akt survival signaling to the ATM protein. J Biol
Chem. 278:48–53. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kusakai G, Suzuki A, Ogura T, Miyamoto S,
Ochiai A, Kaminishi M and Esumi H: ARK5 expression in colorectal
cancer and its implications for tumor progression. Am J Pathol.
164:987–995. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ekstrand AI, Jonsson M, Lindblom A, Borg A
and Nilbert M: Frequent alterations of the PI3K/AKT/mTOR pathways
in hereditary nonpolyposis colorectal cancer. Fam Cancer.
9:125–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li B, Tsao SW, Li YY, Wang X, Ling MT,
Wong YC, He QY and Cheung AL: Id-1 promotes tumorigenicity and
metastasis of human esophageal cancer cells through activation of
PI3K/AKT signaling pathway. Int J Cancer. 125:2576–2585. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohta T, Isobe M, Takahashi T,
Saitoh-Sekiguchi M, Motoyama T and Kurachi H: The Akt and ERK
activation by platinum-based chemotherapy in ovarian cancer is
associated with favorable patient outcome. Anticancer Res.
29:4639–4647. 2009.PubMed/NCBI
|
|
13
|
Simon PO Jr, McDunn JE, Kashiwagi H, Chang
K, Goedegebuure PS, Hotchkiss RS and Hawkins WG: Targeting AKT and
with the proapoptotic peptide, TAT-CTMP: A novel strategy for the
treatment of human pancreatic adenocarcinoma. Int J Cancer.
125:942–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang XZ, Yu J, Liu HY, Dong RH and Cao
XC: ARK5 is associated with the invasive and metastatic potential
of human breast cancercells. J Cancer Res Clin Oncol. 138:247–254.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu S, Niu N, Guo H, Tang J, Guo W, Liu Z,
Shi L, Sun T, Zhou F, Li H, Zhang J and Zhang B: ARK5 promotes
glioma cell invasion, andits elevated expression is correlated with
poorclinical outcome. Eur J Cancer. 49:752–763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bustin SA: Absolute quantification of mRNA
using real-time reverse transcription polymerase chain reaction
assays. J Mol Endocrinol. 25:169–193. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng X, Carstens JL, Kim J, Scheible M,
Kaye J, Sugimoto H, Wu CC, LeBleu VS and Kalluri R:
Epithelialto-mesenchymal transition is dispensable for metastasis
but induces chemoresistance in pancreatic cancer. Nature.
527:525–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, DU F, Zhao Q, Jin J, Ma X and Li H:
Acquisition of 5-fluorouracil resistanceinduces
epithelial-mesenchymal transitions through the Hedgehog signaling
pathway in HCT-8 colon cancer cells. Oncol Lett. 9:2675–2679.
2015.PubMed/NCBI
|
|
19
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes tochemoresistance. Natur. 527:472–476.
2015. View Article : Google Scholar
|
|
20
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: What is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu T, Zhang J, Chen W, Pan S, Zhi X, Wen
L, Zhou Y, Chen BW, Qiu J, Zhang Y, et al: ARK5 promotes
doxorubicin resistance in hepatocellular carcinoma via
epithelial-mesenchymal transition. Cancer Lett. 377:140–148. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang HY, Li JH, Li G and Wang SR:
Activation of ARK5/miR-1181/HOXA10 axis promotes
epithelial-mesenchymal transition in ovarian cancer. Oncol Rep.
34:1193–1202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li M, Zheng C, Xu H, He W, Ruan Y, Ma J,
Zheng J, Ye C and Li W: Inhibition of AMPK-related kinase 5 (ARK5)
enhances cisplatin cytotoxicity in non-small cell lung cancer cells
through regulation of epithelial-mesenchymal transition. Am J
Transl Res. 9:1708–1719. 2017.PubMed/NCBI
|
|
24
|
Park NR, Cha JH, Jang JW, Bae SH, Jang B,
Kim JH, Hur W, Choi JY and Yoon SK: Synergistic effects of CD44 and
TGF-β1 through AKT/GSK-3β/β-catenin signaling during
epithelial-mesenchymal transition in liver cancer cells. Biochem
Biophys Res Commun. 477:568–574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanda M, Sugimoto H and Kodera Y: Genetic
and epigenetic aspects of initiation and progression of
hepatocellular carcinoma. World J Gastroenterol. 21:10584–10597.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawasaki K, Smith RS Jr, Hsieh CM, Sun J,
Chao J and Liao JK: Activation of and the phosphatidylinositol
3-kinase/protein kinase Akt pathway mediates nitric oxide-induced
endothelial cell migration and angiogenesis. Mol Cell Biol.
23:5726–5737. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li G, Satyamoorthy K and Herlyn M:
N-cadherin-mediated intercellular interactions promote survival and
migration of melanoma cells. CancerRes. 61:3819–3825. 2001.
|
|
29
|
Liu W, Liu Y and Lowe WL Jr: The role of
phosphatidylinositol 3-kinaseand the mitogen-activated protein
kinases in insulin-like growth factor-I-mediated effects in
vascular endothelial cells. Endocrinology. 142:1710–1719. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Choi SS and Diehl AM:
Epithelial-to-mesenchymal transitions in the liver. Hepatology.
50:2007–2013. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xia H, Ooi LL and Hui KM:
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets
PTEN and SMAD7 to promote drug resistance and recurrenceof liver
cancer. Hepatology. 58:629–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thomson S, Petti F, Sujka-Kwok I, Mercado
P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM and Haley
JD: A systems view of epithelial-mesenchymal transition signaling
states. Clin Exp Metastasis. 28:137–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen D, Liu G, Xu N, You X, Zhou H, Zhao X
and Liu Q: Knockdown of ARK5 expression suppresses invasion and
metastasis of gastric cancer. Cell Physiol Biochem. 42:1025–1036.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen XF, Zhang HJ, Wang HB, Zhu J, Zhou
WY, Zhang H, Zhao MC, Su JM, Gao W, Zhang L, et al: Transforming
growth factor-β1 induces epithelial-to mesenchymal transition in
human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling
pathways. Mol Biol Rep. 39:3549–3556. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Z, Shen MX, Ma DZ, Wang LY and Zha XL:
TGF-beta1-promoted epithelial-to-mesenchymal transformation and
cell adhesion contribute to TGF-beta1-enhanced cell migration in
SMMC-7721 cells. Cell Res. 13:343–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dang H, Ding W, Emerson D and Rountree CB:
Snail1 induces epithelial-tomesenchymal transition and tumor
initiating stem cell characteristics. BMC Cancer. 11:3962011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ji J and Wang XW: Clinical implications of
cancer stem cell biology in hepatocellular carcinoma. Semin Oncol.
39:461–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang JD, Nakamura I and Roberts LR: The
tumor microenvironment in hepatocellular carcinoma: Current status
and therapeutic targets. Semin Cancer Biol. 21:35–43. 2011.
View Article : Google Scholar : PubMed/NCBI
|
